In China, reports of HMPV infections have indeed been rising in recent weeks in the more northerly regions. But so have ...

Rising cases of common respiratory illnesses in China and elsewhere around the Northern Hemisphere are within the range ...

DNL343 and fosigotifator are made to activate the ISR pathway protein eIF2B, but both failed to slow ALS progression in the HEALEY trial.

No link was found between Competitive Bidding Program implementation and changes in supplemental oxygen use or clinical ...

The whole point of this is to be ready for a new virus so that when it does arrive, which it probably will because we are one ...

Early childhood infections significantly increase the risk of severe infections and antibiotic use later in childhood, ...

A new multi-site study by BIDMC, MGH, BWH, and CDC aims to enhance pandemic preparedness and understand respiratory virus transmission through the CHARM Network.

Topline results from a phase 2/3 clinical trial showed that an eIF2B agonist to treat ALS failed to meet its primary endpoint of slowing disease progression compared with placebo at week 24.According ...

News of a respiratory virus spreading in China and footage of crowded hospitals has predictably led to panic among the people ...

The all-cause hospitalization rate at 28 days is high among adults with outpatient medically attended RSV infections.

Researchers at UC San Diego School of Medicine are serving as the central data hub for the CHARM Network, a new five-year pandemic preparedness initiative funded by the CDC. This includes ensuring ...

Individuals in the lowest quintile of birth weight appear to have an increased risk for subsequent chronic obstructive ...